Growing community of inventors

Basel, Switzerland

Evgenia Rousaki

Average Co-Inventor Count = 4.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Evgenia RousakiArnaud Grandeury (3 patents)Evgenia RousakiStephanie Kay Dodd (3 patents)Evgenia RousakiEmmanuel Suffert (3 patents)Evgenia RousakiEvgenia Rousaki (3 patents)Arnaud GrandeuryArnaud Grandeury (14 patents)Stephanie Kay DoddStephanie Kay Dodd (12 patents)Emmanuel SuffertEmmanuel Suffert (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (3 from 3,923 patents)


3 patents:

1. 12252479 - Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

2. 12252478 - Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

3. 11407735 - Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…